Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2021
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222
Halle C F Moore, William E Barlow, George Somlo, et al.
Journal of the National Cancer Institute
|
July 16, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)
Yara Abdou, Jess Hoag, William E Barlow, et al.
JAMA Oncology
|
December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial
Irene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial
Yara Abdou, William E Barlow, Julie R Gralow, et al.
Nature Genetics
|
November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Cancer Research
|
December 14, 2017
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms
Costanza Paoletti, Andi K Cani, Jose M Larios, et al.
JAMA Oncology
|
February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
Erin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Nature
|
August 8, 2017
Integrative clinical genomics of metastatic cancer
Dan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
The New England Journal of Medicine
|
December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
Kevin Kalinsky, William E Barlow, Julie R Gralow, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 2021
A Randomized Trial of Fulvestrant, Everolimus, and Anastrozole for the Front-line Treatment of Patients with Advanced Hormone Receptor-positive Breast Cancer, SWOG S1222
Halle C F Moore, William E Barlow, George Somlo, et al.
Journal of the National Cancer Institute
|
July 16, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)
Yara Abdou, Jess Hoag, William E Barlow, et al.
JAMA Oncology
|
December 11, 2025
Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial
Irene M Kang, Jamie K Forschmiedt, Michelle M Loch, et al.
Journal of the National Cancer Institute
|
December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial
Yara Abdou, William E Barlow, Julie R Gralow, et al.
Nature Genetics
|
November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Cancer Research
|
December 14, 2017
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms
Costanza Paoletti, Andi K Cani, Jose M Larios, et al.
JAMA Oncology
|
February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
Erin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Nature
|
August 8, 2017
Integrative clinical genomics of metastatic cancer
Dan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
The New England Journal of Medicine
|
December 16, 2021
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
Kevin Kalinsky, William E Barlow, Julie R Gralow, et al.
Page
of 7